Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review

BMC Cancer

Susanne Hartwig⁴  Stina Syrjänen¹  Géraldine Dominiak-Felden⁴  Maria Brotons²  Xavier Castellsagué³ 

[1] Department of Oral Radiology and Pathology, Faculty of Medicine, Institute of Dentistry and MediCity Research Laboratory, Turku, Finland

[2] Cancer Epidemiology Research Program, L'Hospitalet de Llobregat, Institut Català d'Oncologia (ICO)-IDIBELL, Catalonia, Spain

[3] CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain

[4] Department of Epidemiology, Sanofi Pasteur MSD, Lyon, France

关键词: Europe;    Men;    Condylomata acuminata;    Genital warts;    Cancer;    Epidemiology;    HPV;   

Others  :  1080577
DOI  :  10.1186/1471-2407-12-30

 received in 2011-09-16, accepted in 2012-01-20,  发布年份 2012

【 摘 要 】

Background

The role of human papillomavirus (HPV) in malignant and non-malignant genital diseases in women is well known and the corresponding epidemiological burden has been widely described. However, less is known about the role of HPV in anal, penile and head and neck cancer, and the burden of malignant and non-malignant HPV-related diseases in men. The objective of this review is to estimate the epidemiological burden of HPV-related cancers and non-malignant diseases in men in Europe.

Methods

The annual number of new HPV-related cancers in men in Europe was estimated using Eurostat population data and applying cancer incidence rates published by the International Agency for Research on Cancer. The number of cancer cases attributable to HPV, and specifically to HPV16/18, was calculated based on the most relevant prevalence estimates. The annual number of new cases of genital warts was calculated from the most robust European studies; and latest HPV6/11 prevalence estimates were then applied. A literature review was also performed to retrieve exhaustive data on HPV infection at all anatomical sites under study, as well as incidence and prevalence of external genital warts, recurrent respiratory papillomatosis and HPV-related cancer trends in men in Europe.

Results

A total of 72, 694 new cancer cases at HPV-related anatomical sites were estimated to occur each year in men in Europe. 17,403 of these cancer cases could be attributable to HPV, with 15,497 of them specifically attributable to HPV16/18. In addition, between 286,682 and 325,722 new cases of genital warts attributable to HPV6/11were estimated to occur annually in men in Europe.

Conclusions

The overall estimated epidemiological burden of HPV-related cancers and non-malignant diseases is high in men in Europe. Approximately 30% of all new cancer cases attributable to HPV16/18 that occur yearly in Europe were estimated to occur in men. As in women, the vast majority of HPV-positive cancer in men is related to HPV16/18, while almost all HPV-related non-malignant diseases are due to HPV6/11. A substantial number of these malignant and non-malignant diseases may potentially be prevented by quadrivalent HPV vaccination.

【 授权许可】

   
2011 Hartwig et al; licensee BioMed Central Ltd..

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Kjaer SK, Breugelmans G, Munk C, Junge J, Watson M, Iftner T: Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer 2008, 123:1864-1870.
• [2]HPV and cervical cancer in the 2007 report Vaccine 2007, 25 Suppl 3:C1-230. C1-230
• [3]Arbyn M, Castellsague X, deSanjose S, Bruni L, Saraiya M, Bray F, et al.: Worldwide burden of cervical cancer in 2008. Ann Oncol 2011, 22:2675-2686.
• [4]Kjaer SK, Tran TN, Sparen P, Tryggvadottir L, Munk C, Dasbach E, et al.: The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries. J Infect Dis 2007, 196:1447-1454.
• [5]Roteli-Martins CM, de Carvalho NS, Naud P, Teixeira J, Borba P, Derchain S, et al.: Prevalence of human papillomavirus infection and associated risk factors in young women in Brazil, Canada, and the United States: a multicenter cross-sectional study. Int J Gynecol Pathol 2011, 30:173-184.
• [6]Ting J, Kruzikas DT, Smith JS: A global review of age-specific and overall prevalence of cervical lesions. Int J Gynecol Cancer 2010, 20:1244-1249.
• [7]Syrjanen K, Syrjanen S, Lamberg M, Pyrhonen S, Nuutinen J: Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg 1983, 12:418-424.
• [8]Human papillomaviruses IARC Monogr Eval Carcinog Risks Hum 2007, 90:1-636. 1-636
• [9][http://monographs.iarc.fr/ENG/Monographs/vol100B/mono100B.pdf] webcite
• [10]Aubin F, Pretet JL, Jacquard AC, Saunier M, Carcopino X, Jaroud F, et al.: Human papillomavirus genotype distribution in external acuminata condylomata: a Large French National Study (EDiTH IV). Clin Infect Dis 2008, 47:610-615.
• [11]Donne AJ, Hampson L, Homer JJ, Hampson IN: The role of HPV type in Recurrent Respiratory Papillomatosis. Int J Pediatr Otorhinolaryngol 2010, 74:7-14.
• [12]Menton JF, Cremin SM, Canier L, Horgan M, Fanning LJ: Molecular epidemiology of sexually transmitted human papillomavirus in a self referred group of women in Ireland. Virol J 2009, 6:112. 112 BioMed Central Full Text
• [13][http://epp.eurostat.ec.europa.eu/portal/page/portal/eurostat/home] webcite
• [14][http://www.iarc.fr] webcite
• [15]Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Jeanue M, Boyle P: Comparability and quality of data. In Cancer Incidence in Five Containents. [http://www.iarc.fr/en/publications/pdfs-online/epi/sp160/CI5vol9-5.pdf] webcite 2007., 9(Chapter 5)
• [16]Desai S, Wetten S, Woodhall SC, Peters L, Hughes G, Soldan K: Genital warts and cost of care in England. Sex Transm Infect 2011.
• [17]Kraut AA, Schink T, Schulze-Rath R, Mikolajczyk RT, Garbe E: Incidence of anogenital warts in Germany: a population-based cohort study. BMC Infect Dis 2010, 10:360. BioMed Central Full Text
• [18]Kreimer AR, Clifford GM, Boyle P, Franceschi S: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005, 14:467-475.
• [19]De VH, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S: Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009, 124:1626-1636.
• [20]Miralles-Guri C, Bruni L, Cubilla AL, Castellsague X, Bosch FX, de SS: Human papillomavirus prevalence and type distribution in penile carcinoma. J Clin Pathol 2009, 62:870-878.
• [21]Mehanna H, Jones TM, Gregoire V, Ang KK: Oropharyngeal carcinoma related to human papillomavirus. BMJ 2010, 340:c1439.
• [22]Hammarstedt L, Dahlstrand H, Lindquist D, Onelov L, Ryott M, Luo J, et al.: The incidence of tonsillar cancer in Sweden is increasing. Acta Otolaryngol 2007, 127:988-992.
• [23]Nasman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G, et al.: Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 2009, 125:362-366.
• [24]Brewster DH, Bhatti LA: Increasing incidence of squamous cell carcinoma of the anus in Scotland, 1975-2002. Br J Cancer 2006, 95:87-90.
• [25]Frisch M, Melbye M, Moller H: Trends in incidence of anal cancer in Denmark. BMJ 1993, 306:419-422.
• [26]Nielsen A, Munk C, Kjaer SK: Trends in incidence of anal cancer and high-grade anal intraepithelial neoplasia in Denmark, 1978-2008. Int J Cancer 2011, 10.
• [27]Goldman S, Glimelius B, Nilsson B, Pahlman L: Incidence of anal epidermoid carcinoma in Sweden 1970-1984. Acta Chir Scand 1989, 155:191-197.
• [28]Van Lieshout A, Pronk A: [Increasing incidence of anal cancer in the Netherlands]. Ned Tijdschr Geneeskd 2010, 154:A1163.
• [29]Graafland NM, Verhoeven RH, Coebergh JW, Horenblas S: Incidence trends and survival of penile squamous cell carcinoma in the Netherlands. Int J Cancer 2011, 128:426-432.
• [30]Castellsague X, Cohet C, Puig-Tintore LM, Acebes LO, Salinas J, San MM, et al.: Epidemiology and cost of treatment of genital warts in Spain. Eur J Public Health 2009, 19:106-110.
• [31]Hippelainen M, Syrjanen S, Hippelainen M, Koskela H, Pulkkinen J, Saarikoski S, et al.: Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts. Sex Transm Dis 1993, 20:321-328.
• [32]Kataoka A, Claesson U, Hansson BG, Eriksson M, Lindh E: Human papillomavirus infection of the male diagnosed by Southern-blot hybridization and polymerase chain reaction: comparison between urethra samples and penile biopsy samples. J Med Virol 1991, 33:159-164.
• [33]Simms I, Fairley CK: Epidemiology of genital warts in England and Wales: 1971 to 1994. Genitourin Med 1997, 73:365-367.
• [34]Cassell JA, Mercer CH, Sutcliffe L, Petersen I, Islam A, Brook MG, et al.: Trends in sexually transmitted infections in general practice 1990-2000: population based study using data from the UK general practice research database. BMJ 2006, 332:332-334.
• [35]Fenton KA, Korovessis C, Johnson AM, McCadden A, McManus S, Wellings K, et al.: Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet 2001, 358:1851-1854.
• [36]Persson G, Andersson K, Krantz I: Symptomatic genital papillomavirus infection in a community. Incidence and clinical picture. Acta Obstet Gynecol Scand 1996, 75:287-290.
• [37]Bleeker MC, Hogewoning CJ, van den Brule AJ, Voorhorst FJ, Van Andel RE, Risse EK, et al.: Penile lesions and human papillomavirus in male sexual partners of women with cervical intraepithelial neoplasia. J Am Acad Dermatol 2002, 47:351-357.
• [38]Kyriakis KP, Hadjivassiliou M, Paparizos VA, Riga P, Katsambas A: Determinants of genital wart case detection rates among STD clinic attendees in Athens, Greece. Int J Dermatol 2005, 44:650-653.
• [39]Svare EI, Kjaer SK, Worm AM, Osterlind A, Meijer CJ, van den Brule AJ: Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic. Sex Transm Infect 2002, 78:215-218.
• [40]van der Snoek EM, Niesters HG, Mulder PG, Van Doornum GJ, Osterhaus AD, van der Meijden WI: Human papillomavirus infection in men who have sex with men participating in a Dutch gay-cohort study. Sex Transm Dis 2003, 30:639-644.
• [41][http://www.hpa.org.uk/] webcite
• [42]Lindeberg H, Elbrond O: Laryngeal papillomas: the epidemiology in a Danish subpopulation 1965-1984. Clin Otolaryngol Allied Sci 1990, 15:125-131.
• [43]Silverberg MJ, Thorsen P, Lindeberg H, Grant LA, Shah KV: Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis. Obstet Gynecol 2003, 101:645-652.
• [44]Eike A, Buchwald C, Rolighed J, Lindeberg H: Human papillomavirus (HPV) is rarely present in normal oral and nasal mucosa. Clin Otolaryngol Allied Sci 1995, 20:171-173.
• [45]Van Doornum GJ, Hooykaas C, Juffermans LH, van der Lans SM, van der Linden MM, Coutinho RA, et al.: Prevalence of human papillomavirus infections among heterosexual men and women with multiple sexual partners. J Med Virol 1992, 37:13-21.
• [46]Rintala M, Grenman S, Puranen M, Syrjanen S: Natural history of oral papillomavirus infections in spouses: a prospective Finnish HPV Family Study. J Clin Virol 2006, 35:89-94.
• [47]Kujan O, Desai M, Sargent A, Bailey A, Turner A, Sloan P: Potential applications of oral brush cytology with liquid-based technology: results from a cohort of normal oral mucosa. Oral Oncol 2006, 42:810-818.
• [48]Montaldo C, Mastinu A, Quartuccio M, Piras V, Denotti G, Pisano E, et al.: Detection and genotyping of human papillomavirus DNA in samples from healthy Sardinian patients: a preliminary study. J Oral Pathol Med 2007, 36:482-487.
• [49]Van Doornum GJ, Prins M, Juffermans LH, Hooykaas C, van den Hoek JA, Coutinho RA, et al.: Regional distribution and incidence of human papillomavirus infections among heterosexual men and women with multiple sexual partners: a prospective study. Genitourin Med 1994, 70:240-246.
• [50]Lowhagen GB, Bergbrant IM, Bergstrom T, Ryd W, Voog E: PCR detection of Epstein-Barr virus, herpes simplex virus and human papillomavirus from the anal mucosa in HIV-seropositive and HIV-seronegative homosexual men. Int J STD AIDS 1999, 10:615-618.
• [51]Piketty C, Darragh TM, Da CM, Bruneval P, Heard I, Kazatchkine MD, et al.: High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med 2003, 138:453-459.
• [52]Sirera G, Videla S, Pinol M, Canadas MP, Llatjos M, Ballesteros AL, et al.: High prevalence of human papillomavirus infection in the anus, penis and mouth in HIV-positive men. AIDS 2006, 20:1201-1204.
• [53]Aynaud O, Poveda JD, Huynh B, Guillemotonia A, Barrasso R: Frequency of herpes simplex virus, cytomegalovirus and human papillomavirus DNA in semen. Int J STD AIDS 2002, 13:547-550.
• [54]Bleeker MC, Hogewoning CJ, Berkhof J, Voorhorst FJ, Hesselink AT, van Diemen PM, et al.: Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads. Clin Infect Dis 2005, 41:612-620.
• [55]Barzon L, Militello V, Pagni S, Franchin E, Dal BF, Mengoli C, et al.: Distribution of human papillomavirus types in the anogenital tract of females and males. J Med Virol 2010, 82:1424-1430.
• [56]Pierangeli A, Scagnolari C, Degener AM, Bucci M, Ciardi A, Riva E, et al.: Type-specific human papillomavirus-DNA load in anal infection in HIV-positive men. AIDS 2008, 22:1929-1935.
• [57]Kjaer SK, Munk C, Winther JF, Jorgensen HO, Meijer CJ, van den Brule AJ: Acquisition and persistence of human papillomavirus infection in younger men: a prospective follow-up study among Danish soldiers. Cancer Epidemiol Biomarkers Prev 2005, 14:1528-1533.
• [58]Wikstrom A, Lidbrink P, Johansson B, von KG: Penile human papillomavirus carriage among men attending Swedish STD clinics. Int J STD AIDS 1991, 2:105-109.
• [59]Forslund O, Hansson BG, Rymark P, Bjerre B: Human papillomavirus DNA in urine samples compared with that in simultaneously collected urethra and cervix samples. J Clin Microbiol 1993, 31:1975-1979.
• [60]Franceschi S, Castellsague X, Dal ML, Smith JS, Plummer M, Ngelangel C, et al.: Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer 2002, 86:705-711.
• [61]Hillman RJ, Ryait BK, Botcherby M, Taylor-Robinson D: Human papillomavirus DNA in the urogenital tracts of men with gonorrhoea, penile warts or genital dermatoses. Genitourin Med 1993, 69:187-192.
• [62]Aynaud O, Ionesco M, Barrasso R: Cytologic detection of human papillomavirus DNA in normal male urethral samples. Urology 2003, 61:1098-1101.
• [63]Giovannelli L, Migliore MC, Capra G, Caleca MP, Bellavia C, Perino A, et al.: Penile, urethral, and seminal sampling for diagnosis of human papillomavirus infection in men. J Clin Microbiol 2007, 45:248-251.
• [64]Benevolo M, Mottolese M, Marandino F, Carosi M, Diodoro MG, Sentinelli S, et al.: HPV prevalence among healthy Italian male sexual partners of women with cervical HPV infection. J Med Virol 2008, 80:1275-1281.
• [65]Bleeker MC, Hogewoning CJ, Voorhorst FJ, van den Brule AJ, Berkhof J, Hesselink AT, et al.: HPV-associated flat penile lesions in men of a non-STD hospital population: less frequent and smaller in size than in male sexual partners of women with CIN. Int J Cancer 2005, 113:36-41.
• [66]Castellsague X, Ghaffari A, Daniel RW, Bosch FX, Munoz N, Shah KV: Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia. J Infect Dis 1997, 176:353-361.
• [67]Bosch FX, Castellsague X, Munoz N, de SS, Ghaffari AM, Gonzalez LC, et al.: Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain. J Natl Cancer Inst 1996, 88:1060-1067.
• [68]Voog E, Ricksten A, Olofsson S, Ternesten A, Ryd W, Kjellstrom C, et al.: Demonstration of Epstein-Barr virus DNA and human papillomavirus DNA in acetowhite lesions of the penile skin and the oral mucosa. Int J STD AIDS 1997, 8:772-775.
• [69]Strand A, Rylander E, Evander M, Wadell G: Genital human papillomavirus infection among patients attending an STD clinic. Genitourin Med 1993, 69:446-449.
• [70]Lacey CJ, Lowndes CM, Shah KV: Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 2006, 24 Suppl 3:S3/35-41. S3-35-S3/41
• [71]Ramqvist T, Dalianis T: An epidemic of oropharyngeal squamous cell carcinoma (OSCC) due to human papillomavirus (HPV) infection and aspects of treatment and prevention. Anticancer Res 2011, 31:1515-1519.
• [72]Attner P, Du J, Nasman A, Hammarstedt L, Ramqvist T, Lindholm J, et al.: The role of human papillomavirus in the increased incidence of base of tongue cancer. Int J Cancer 2010, 126:2879-2884.
• [73]Hobbs CG, Sterne JA, Bailey M, Heyderman RS, Birchall MA, Thomas SJ: Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clin Otolaryngol 2006, 31:259-266.
• [74]Syrjanen S: HPV infections and tonsillar carcinoma. J Clin Pathol 2004, 57:449-455.
• [75]Colon-Lopez V, Ortiz AP, Palefsky J: Burden of human papillomavirus infection and related comorbidities in men: implications for research, disease prevention and health promotion among Hispanic men. P R Health Sci J 2010, 29:232-240.
• [76]Palefsky JM, Rubin M: The epidemiology of anal human papillomavirus and related neoplasia. Obstet Gynecol Clin North Am 2009, 36:187-200.
• [77]Giuliano AR, Anic G, Nyitray AG: Epidemiology and pathology of HPV disease in males. Gynecol Oncol 2010, 117:S15-S19.
• [78]Parkin DM, Bray F: Chapter 2: The burden of HPV-related cancers. Vaccine 2006, 24 Suppl 3:S3/11-25. S3- 11-S3/25
• [79]Backes DM, Kurman RJ, Pimenta JM, Smith JS: Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control 2009, 20:449-457.
• [80]Castellsague X, Albero G, Cleries R, Bosch FX: HPV and circumcision: a biased, inaccurate and misleading meta-analysis. J Infect 2007, 55:91-93.
• [81][http://www.hpa.org.uk/] webcite
• [82]Maw RD, Reitano M, Roy M: An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle. Int J STD AIDS 1998, 9:571-578.
• [83]Woodhall S, Ramsey T, Cai C, Crouch S, Jit M, Birks Y, et al.: Estimation of the impact of genital warts on health-related quality of life. Sex Transm Infect 2008, 84:161-166.
• [84]Kreimer AR, Bhatia RK, Messeguer AL, Gonzalez P, Herrero R, Giuliano AR: Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis 2010, 37:386-391.
• [85]Kreimer AR, Villa A, Nyitray A, Abrahamsen ME, Papenfuss MR, Smith D, et al.: The epidemiology of oral HPV infection among a multinational sample of healthy men. Cancer Epidemiol Biomarkers Prev 2010.
• [86]Smith JS, Gilbert PA, Melendy A, Rana RK, Pimenta JM: Age-specific prevalence of human papillomavirus infection in males: a global review. J Adolesc Health 2011, 48:540-552.
• [87]Giuliano AR, Lazcano-Ponce E, Villa LL, Flores R, Salmeron J, Lee JH, et al.: The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev 2008, 17:2036-2043.
• [88]Nielson CM, Harris RB, Dunne EF, Abrahamsen M, Papenfuss MR, Flores R, et al.: Risk factors for anogenital human papillomavirus infection in men. J Infect Dis 2007, 196:1137-1145.
• [89]Giuliano AR, Lee JH, Fulp W, Villa LL, Lazcano E, Papenfuss MR, et al.: Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet 2011, 377:932-940.
• [90]Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H, et al.: Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect Dis 2011, 11:39-44.